Peter Ferenci

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Gabriela Berlakovich

Medical University of Vienna

AUSTRIA

View details

Teresa Binter

Medical University of Vienna

AUSTRIA

View details

Thomas Stimpfl

Medical University of Vienna

AUSTRIA

View details

Vanessa Stadlbauer

AUSTRIA

View details

Albert Stättermayer

Medical University of Vienna

AUSTRIA

View details

Markus Peck‐Radosavljevic

AUSTRIA

View details

Heinz Zoller

AUSTRIA

View details

Thomas Waldhoer

Professor

Medical University of Vienna

AUSTRIA

View details

Thomas Reiberger

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Ferenci

Research Interests

Explore related searches

Contact this professor

Articles (11)

Portal hypertension and its prognostic implications in patients with Wilson's disease

Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?

Letter: chronic HDV infection—is ignorance bliss? Authors' reply

Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update

Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer? Authors' reply

Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network—A Competing Risk Analysis

Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis

Designing Clinical Trials in Wilson’s Disease

MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective

Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR

Collaborators (9)

Gabriela Berlakovich

Teresa Binter

Thomas Stimpfl

Vanessa Stadlbauer

Albert Stättermayer

Markus Peck‐Radosavljevic

Heinz Zoller

Thomas Waldhoer

Thomas Reiberger

Make your next move.